We are seeking strategic partnerships through which we can broadly expand our drug discovery efforts to new disease targets in specific therapeutic areas. Specifically, we are interested in partnerships with organizations who are interested in developing single domain antibody based therapeutics in areas where our novel and proprietary technology offers competitive advantages. We are looking from our partners to provide expertise, tools and resources that complement our drug discovery efforts.

Singh Biotechnology is flexible and adaptable in considering different approaches to drug discovery collaborations. Such as but not limited to:

  • Fully Funded Target Collaborations

  • Co-Discovery/Co-Development Collaborations

  • IND Generation Collaborations

  • Strategic Partnerships

To learn more about drug discovery collaborations and licensing opportunities with Singh Biotechnology, Please Contact: [email protected]